Mohammed Kashani-Sabet

Guest Editor for the following articles:

Mar
2003
Vol. 22. No. 1

The New Melanoma Staging System

Arthur J. Sober, MD | Charles M. Balch, MD | Seng-jaw Soong, PhD | Jeffrey E Gershenwald, MD

Physicians managing melanoma should use this staging system in their clinical practice and in the conduct of melanoma clinical trials.

MORE
Mar
2003
Vol. 22. No. 1

Adjuvant Therapy of Melanoma

Larisa Geskin, MD | C Romen Brown, MD | John M Kirkwood, MD

Melanoma incidence is rising faster than other solid tumors, with an increase in incidence of a 1000% since 1935. The US death toll attributable to melanoma in 2002 approaches 8,000 people a year.

MORE
Mar
2003
Vol. 22. No. 1

Melanoma Vaccines: Early Progress and Future Promises

John M Kirkwood, MD | Hassane M Zarour, MD

Ample evidence exists to suggest that immune responses may develop in patients with melanoma. Although tumors are usually considered poorly immunogenic, melanoma is one of the most immunogenic among the human solid tumors.

MORE